RXST (RXST)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$242.05M
EV / Sales1.90
EV / EBITDA-5.60
EV / Operating Cash Flow-13.78
EV / Free Cash Flow-11.21

Return Metrics (TTM)

Return on Equity (ROE)-17.01%
Return on Assets (ROA)-15.34%
Return on Invested Capital (ROIC)-19.90%
Return on Capital Employed (ROCE)-20.01%

Yield Metrics

Earnings Yield-18.79%
Free Cash Flow Yield-8.68%

Balance Sheet Strength

Net Debt / EBITDA0.16
Current Ratio10.20
Working Capital$251.85M
Tangible Asset Value$267.30M
Net Current Asset Value$242.53M

Working Capital Efficiency

Days Sales Outstanding64.26
Days Payables Outstanding88.75
Operating Cycle (Days)498.65
Cash Conversion Cycle409.90

Capital Allocation

CapEx / Revenue3.15%
CapEx / Operating Cash Flow-22.85%
R&D / Revenue29.54%
SG&A / Revenue90.89%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin76.60%
Operating Margin-35.84%
Net Profit Margin-28.96%

Solvency

Debt / Equity0.04
Quick Ratio9.75
Cash Ratio0.76

Per Share

Revenue / Share$3.27
FCF / Share-$0.47
PE Ratio-10.97